156 related articles for article (PubMed ID: 32602102)
1. Cutaneous Metastases from Testicular Diffuse Large B-cell Malignant Lymphoma and Bowen Disease: 18F-FDG PET-CT Findings.
Mikami T; Ichikawa T; Kazama T; Aoyama Y; Mabuchi T; Ikoma H; Kajiwara H; Nagafuji Y; Sekiguchi Y; Kodama E; Fukuzawa T; Kuroki T; Nagao R; Hashimoto J
Tokai J Exp Clin Med; 2020 Jul; 45(2):58-62. PubMed ID: 32602102
[TBL] [Abstract][Full Text] [Related]
2. Distal appendicular skeletal involvement of diffuse large B-cell lymphoma on technetium-99m methylenediphosphonate bone scintigraphy and
Park I; Kang S
J Med Case Rep; 2017 Apr; 11(1):89. PubMed ID: 28372572
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Importance of Bone Marrow Uptake on Baseline
Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT in the diagnosis of an extranodal relapse of diffuse large B-cell lymphoma (DLBCL): a clinical case with a literature review.
Chaushev B; Micheva I; Mechmed M; Balev B; Bocheva Y; Ivanova D; Krasnaliev I; Lozanova R; Klisarova A; Bochev P; Dancheva J
Nucl Med Rev Cent East Eur; 2016; 19(B):11-13. PubMed ID: 27813622
[TBL] [Abstract][Full Text] [Related]
5. (18)FDG PET/CT appearance in primary cutaneous diffuse large B-cell lymphoma, leg type.
Samarghandi A; Gru AA; Natwa M; Barker DW
Clin Nucl Med; 2015 Jun; 40(6):506-8. PubMed ID: 25742229
[TBL] [Abstract][Full Text] [Related]
6. Zosteriform Secondary Cutaneous Diffuse Large B-Cell Lymphoma on FDG PET/CT.
Liao CW; Yen KY; Hsieh TC; Kao CH
Clin Nucl Med; 2016 Sep; 41(9):701-2. PubMed ID: 27405036
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
8. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723
[TBL] [Abstract][Full Text] [Related]
9. Functional Parameters of
Yang J; Zhu S; Pang F; Xu M; Dong Y; Hao J; Ma X
Contrast Media Mol Imaging; 2018; 2018():8659826. PubMed ID: 30363729
[TBL] [Abstract][Full Text] [Related]
10. A rare case of Diffuse Large B-Cell Lymphoma of the Prostate on 18F-FDG PET-CT.
Usmani S; Ahmed DAT; Hamadah A; Al Kandari F
J Pak Med Assoc; 2021 Jan; 71(1(B)):388-389. PubMed ID: 35157690
[TBL] [Abstract][Full Text] [Related]
11. 18FDG PET/CT in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type.
Dejust S; Morland D; Durot E; Grange F; Papathanassiou D
Clin Nucl Med; 2020 May; 45(5):403-404. PubMed ID: 32209875
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of post-treatment
An YS; Yoon JK; Lee SJ; Jeong SH; Lee HW
Eur Radiol; 2016 Dec; 26(12):4632-4639. PubMed ID: 27193777
[TBL] [Abstract][Full Text] [Related]
13. Multiple Subcutaneous Nodules as Initial Presentation of Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL) Detected by PET/CT.
Shen G; Kou Y; Liu B; Kuang A
Clin Nucl Med; 2018 Oct; 43(10):759-761. PubMed ID: 30059432
[TBL] [Abstract][Full Text] [Related]
14. FDG PET/CT Findings in Primary Diffuse Large B-cell Lymphoma, Leg Type.
Ni C; Lewis M; Berenji G
Clin Nucl Med; 2016 Jan; 41(1):65-8. PubMed ID: 26447379
[TBL] [Abstract][Full Text] [Related]
15. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring.
Minamimoto R; Fayad L; Advani R; Vose J; Macapinlac H; Meza J; Hankins J; Mottaghy F; Juweid M; Quon A
Radiology; 2016 Jul; 280(1):220-9. PubMed ID: 26854705
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.
Zhou M; Chen Y; Huang H; Zhou X; Liu J; Huang G
Oncotarget; 2016 Dec; 7(50):83544-83553. PubMed ID: 27835875
[TBL] [Abstract][Full Text] [Related]
19. 18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
Kumar R; Xiu Y; Zhuang HM; Alavi A
Br J Dermatol; 2006 Aug; 155(2):357-63. PubMed ID: 16882175
[TBL] [Abstract][Full Text] [Related]
20. Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients.
Roland V; Bodet-Milin C; Moreau A; Gastinne T; Mahé B; Dubruille V; Maisonneuve H; Juge-Morineau N; Moreau P; Jardel H; Planche L; Mohty M; Moreau P; Harousseau JL; Kraeber-Bodéré F; Le Gouill S
Bone Marrow Transplant; 2011 Mar; 46(3):393-9. PubMed ID: 20577223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
